Click Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference


NEW YORK – April 13, 2023 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2023 at 2:15 p.m. ET.

Company management will also participate in one-on-one meetings during the conference, which will be held virtually on April 17-20, 2023.

About Click Therapeutics

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click is progressing a broad pipeline of Digital Therapeutics™ across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Migraine, Multiple Sclerosis, Chronic Pain, Atopic Dermatitis, Acute Coronary Syndrome, Obesity, Oncology and more. For more information on Click, visit

Investor Contact

Daniel Busby

Media Contact

Jonni Mills